Immediate Impact
65 standout
Citing Papers
Advances in diagnosis and treatment of bladder cancer
2024 Standout
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Works of William P. Levin being referenced
697O A phase III, randomized, open-label study of first-line durvalumab (D) with or without tremelimumab (T) vs standard of care chemotherapy in patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE)
2020
Proton beam therapy
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| William P. Levin | 681 | 339 | 246 | 60 | 998 | |
| Derek Wilke | 445 | 240 | 212 | 49 | 882 | |
| Takayuki Ohguri | 557 | 291 | 85 | 53 | 1.1k | |
| Ian Rabinowitz | 380 | 344 | 196 | 48 | 1.3k | |
| Sylvie Helfré | 570 | 175 | 320 | 74 | 958 | |
| Daisuke Miyawaki | 492 | 201 | 219 | 81 | 1.0k | |
| Christopher D. Koprowski | 689 | 345 | 309 | 29 | 1.1k | |
| Patrizia Ciammella | 732 | 214 | 518 | 83 | 1.3k | |
| Tobias Bölling | 534 | 214 | 126 | 46 | 1.3k | |
| Michael J. Katin | 805 | 225 | 336 | 44 | 1.1k | |
| Samir H. Patel | 696 | 358 | 485 | 115 | 1.4k |
All Works
Loading papers...